These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3919579)
21. Mitoxantrone in the treatment of relapsed and refractory acute leukemia. Moore JO; Olsen GA Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265 [TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522 [TBL] [Abstract][Full Text] [Related]
23. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Bodey GP; Gehan EA; Freireich EJ; Frei E Am J Med Sci; 1971 Sep; 262(3):138-51. PubMed ID: 5142054 [No Abstract] [Full Text] [Related]
24. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Paciucci PA; Cuttner J; Holland JF Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264 [TBL] [Abstract][Full Text] [Related]
25. [Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia]. Wakita A; Murase T; Uchida T; Fujiwara Y; Tanaka M; Ohkita T Gan To Kagaku Ryoho; 1992 May; 19(5):653-7. PubMed ID: 1580638 [TBL] [Abstract][Full Text] [Related]
26. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A; N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283 [TBL] [Abstract][Full Text] [Related]
27. Intensification therapy for acute nonlymphoblastic leukemia in adults. Glucksberg H; Cheever MA; Farewell VT; Fefer A; Thomas ED Cancer; 1983 Jul; 52(2):198-205. PubMed ID: 6344977 [TBL] [Abstract][Full Text] [Related]
28. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine. Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786 [TBL] [Abstract][Full Text] [Related]
29. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A; N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284 [TBL] [Abstract][Full Text] [Related]
30. Septicemia during compromised host treated in a protected isolation unit. Nagao T; Watanabe K; Komatsuda M; Arimori S; Sawamura S; Ozawa A; Shotsu A; Sasaki S Tokai J Exp Clin Med; 1980 Jan; 5(1):91-5. PubMed ID: 6770498 [TBL] [Abstract][Full Text] [Related]
31. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials. Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961 [TBL] [Abstract][Full Text] [Related]
34. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age. Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115 [TBL] [Abstract][Full Text] [Related]
35. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis. Nguyen AD; Heil EL; Patel NK; Duffy A; Gilmore S J Oncol Pharm Pract; 2016 Apr; 22(2):303-7. PubMed ID: 25567517 [TBL] [Abstract][Full Text] [Related]
36. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Schimpff SC; Greene WH; Young VM; Fortner CL; Cusack N; Block JB; Wiernik PH Ann Intern Med; 1975 Mar; 82(3):351-8. PubMed ID: 1054222 [TBL] [Abstract][Full Text] [Related]
37. Effect of trimethoprim/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia. A Pediatric Oncology Group Study. van Eys J; Berry DM; Crist W; Doering EJ; Fernbach DJ; Pullen J; Shuster J Cancer; 1987 Jan; 59(1):19-23. PubMed ID: 3539306 [TBL] [Abstract][Full Text] [Related]
38. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia. Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623 [TBL] [Abstract][Full Text] [Related]